Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.

Lee PC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Brice A, Vidailhet M, Corvol JC, Elbaz A; DIGPD Study Group.

Mov Disord. 2019 Sep 13. doi: 10.1002/mds.27854. [Epub ahead of print]

PMID:
31518456
2.

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig TD, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, Sixel-Döring F, Weiss D, Witjas T, Thobois S, Agid Y, Schnitzler A, Schuepbach WMM, Timmermann L, Damier P, Vidailhet M, Deuschl G; EARLYSTIM study group.

Parkinsonism Relat Disord. 2019 Aug;65:217-223. doi: 10.1016/j.parkreldis.2019.05.023. Epub 2019 Jun 18.

PMID:
31257096
3.

Repetitive transcranial magnetic stimulation for functional tremor: A randomized, double-blind, controlled study.

Taib S, Ory-Magne F, Brefel-Courbon C, Moreau Y, Thalamas C, Arbus C, Simonetta-Moreau M.

Mov Disord. 2019 Aug;34(8):1210-1219. doi: 10.1002/mds.27727. Epub 2019 Jun 10.

PMID:
31180620
4.

How to diagnose parkinsonian central pain?

Marques A, Attal N, Bouhassira D, Moisset X, Cantagrel N, Rascol O, Durif F, Brefel-Courbon C.

Parkinsonism Relat Disord. 2019 Jul;64:50-53. doi: 10.1016/j.parkreldis.2019.04.025. Epub 2019 May 1.

PMID:
31072757
5.

Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?

Mariani LL, Doulazmi M, Chaigneau V, Brefel-Courbon C, Carrière N, Danaila T, Defebvre L, Defer G, Dellapina E, Doé de Maindreville A, Geny C, Maltête D, Meissner WG, Rascol O, Thobois S, Torny F, Tranchant C, Vidailhet M, Corvol JC, Degos B; NS-Park/F-CRIN Network study group.

Parkinsonism Relat Disord. 2019 Jul;64:226-234. doi: 10.1016/j.parkreldis.2019.04.012. Epub 2019 Apr 25.

PMID:
31047798
6.

[Centers for the management of Parkinson's disease].

Brefel-Courbon C, Rémy P.

Rev Prat. 2018 May;68(5):520-521. French. No abstract available.

PMID:
30869417
7.

Reversible myoclonus-ataxia encephalitis related to anti-mGLUR1 autoantibodies.

Gollion C, Dupouy J, Roberts M, Simonetta-Moreau M, Brefel Courbon C, Rascol O, Honnorat J, Magne FO.

Mov Disord. 2019 Mar;34(3):438-439. doi: 10.1002/mds.27634. Epub 2019 Feb 13. No abstract available.

PMID:
30759326
8.

Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type.

Vergnet S, Hives F, Foubert-Samier A, Payoux P, Fernandez P, Meyer M, Dupouy J, Brefel-Courbon C, Ory-Magne F, Rascol O, Tison F, Pavy-Le Traon A, Meissner WG.

Parkinsonism Relat Disord. 2019 Jun;63:199-203. doi: 10.1016/j.parkreldis.2019.02.006. Epub 2019 Feb 5.

PMID:
30745212
9.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

10.

Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson's disease: a correlation study.

Dellapina E, Pellaprat J, Adel D, Llido J, Harroch E, Martini JB, Kas A, Salabert AS, Ory-Magne F, Payoux P, Brefel-Courbon C.

J Neural Transm (Vienna). 2019 Mar;126(3):279-287. doi: 10.1007/s00702-019-01974-5. Epub 2019 Jan 31.

PMID:
30706197
11.

LRP10 in α-synucleinopathies.

Tesson C, Brefel-Courbon C, Corvol JC, Lesage S, Brice A; French Parkinson's Disease Genetics Study Group.

Lancet Neurol. 2018 Dec;17(12):1034. doi: 10.1016/S1474-4422(18)30400-9. Epub 2018 Nov 13. No abstract available.

12.

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.

Cormier-Dequaire F, Bekadar S, Anheim M, Lebbah S, Pelissolo A, Krack P, Lacomblez L, Lhommée E, Castrioto A, Azulay JP, Defebvre L, Kreisler A, Durif F, Marques-Raquel A, Brefel-Courbon C, Grabli D, Roze E, Llorca PM, Ory-Magne F, Benatru I, Ansquer S, Maltête D, Tir M, Krystkowiak P, Tranchant C, Lagha-Boukbiza O, Lebrun-Vignes B, Mangone G, Vidailhet M, Charbonnier-Beaupel F, Rascol O, Lesage S, Brice A, Tezenas du Montcel S, Corvol JC; BADGE-PD study group.

Mov Disord. 2018 Dec;33(12):1878-1886. doi: 10.1002/mds.27519. Epub 2018 Nov 16.

PMID:
30444952
13.

Molecular Imaging of Opioid System in Idiopathic Parkinson's Disease.

Thobois S, Brefel-Courbon C, Le Bars D, Sgambato-Faure V.

Int Rev Neurobiol. 2018;141:275-303. doi: 10.1016/bs.irn.2018.07.029. Epub 2018 Aug 13. Review.

PMID:
30314599
14.

Longitudinal analysis of impulse control disorders in Parkinson disease.

Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A; DIGPD Study Group.

Neurology. 2018 Jul 17;91(3):e189-e201. doi: 10.1212/WNL.0000000000005816. Epub 2018 Jun 20.

15.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
16.

Abnormal pain perception in patients with Multiple System Atrophy.

Ory-Magne F, Pellaprat J, Harroch E, Galitzsky M, Rousseau V, Pavy-Le Traon A, Rascol O, Gerdelat A, Brefel-Courbon C.

Parkinsonism Relat Disord. 2018 Mar;48:28-33. doi: 10.1016/j.parkreldis.2017.12.001. Epub 2017 Dec 8.

PMID:
29254664
17.

Combined cardiovascular and sweating autonomic testing to differentiate multiple system atrophy from Parkinson's disease.

Pavy-LeTraon A, Brefel-Courbon C, Dupouy J, Ory-Magne F, Rascol O, Senard JM.

Neurophysiol Clin. 2018 Apr;48(2):103-110. doi: 10.1016/j.neucli.2017.11.003. Epub 2017 Dec 14.

PMID:
29249575
18.

Chronic pain and pain processing in Parkinson's disease.

Blanchet PJ, Brefel-Courbon C.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):200-206. doi: 10.1016/j.pnpbp.2017.10.010. Epub 2017 Oct 12. Review.

PMID:
29031913
19.

Cognitive complaint in early Parkinson's disease: A pilot study.

Dupouy J, Ory-Magne F, Mekies C, Rousseau V, Puel M, Rerat K, Pariente J, Brefel-Courbon C; PARKMIP group.

Acta Neurol Scand. 2018 Jan;137(1):59-66. doi: 10.1111/ane.12808. Epub 2017 Aug 22.

PMID:
28832893
20.

Parkinson's patients can rely on perspective cues to perceive 3D space.

Séverac Cauquil A, Ory-Magne F, Jardiné V, Galitzky M, Rosito M, Brefel-Courbon C, Celebrini S.

Brain Res. 2017 May 15;1663:161-165. doi: 10.1016/j.brainres.2017.03.017. Epub 2017 Mar 19.

PMID:
28327351
21.

[Other care in Parkinson's disease: Psychological, rehabilitation, therapeutic education and new technologies].

Dupouy J, Ory-Magne F, Brefel-Courbon C.

Presse Med. 2017 Mar;46(2 Pt 1):225-232. doi: 10.1016/j.lpm.2016.11.009. Epub 2016 Dec 28. Review. French.

PMID:
28040344
22.

Characterization of Burning Mouth Syndrome in Patients with Parkinson's Disease.

Bonenfant D, Rompré PH, Rei N, Jodoin N, Soland VL, Rey V, Brefel-Courbon C, Ory-Magne F, Rascol O, Blanchet PJ.

J Oral Facial Pain Headache. 2016 Fall;30(4):318-322. doi: 10.11607/ofph.1691.

PMID:
27792799
23.

Clinical Impact and Cost-Effectiveness of an Education Program for PD Patients: A Randomized Controlled Trial.

Canivet C, Costa N, Ory-Magne F, Arcari C, Mohara C, Pourcel L, Derumeaux H, Bérard E, Bourrel R, Molinier L, Brefel-Courbon C.

PLoS One. 2016 Sep 29;11(9):e0162646. doi: 10.1371/journal.pone.0162646. eCollection 2016.

24.

Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man.

Saint-Aubert L, Pariente J, Dumas H, Payoux P, Brandel JP, Puel M, Vital A, Guedj E, Lesage S, Peoc'h K, Brefel Courbon C, Ory Magne F.

BMC Neurol. 2016 Jul 30;16:122. doi: 10.1186/s12883-016-0643-y.

25.

Impact of Mood and Behavioral Disorders on Quality of Life in Parkinson's disease.

Rieu I, Houeto JL, Pereira B, De Chazeron I, Bichon A, Chéreau I, Ulla M, Brefel-Courbon C, Ory-Magne F, Dujardin K, Tison F, Krack P, Durif F.

J Parkinsons Dis. 2016;6(1):267-77. doi: 10.3233/JPD-150747.

PMID:
27003781
26.

Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia.

Pouclet-Courtemanche H, Rouaud T, Thobois S, Nguyen JM, Brefel-Courbon C, Chereau I, Cuny E, Derost P, Eusebio A, Guehl D, Laurencin C, Mertens P, Ory-Magne F, Raoul S, Regis J, Ulla M, Witjas T, Burbaud P, Rascol O, Damier P.

Neurology. 2016 Feb 16;86(7):651-9. doi: 10.1212/WNL.0000000000002370. Epub 2016 Jan 20.

PMID:
26791148
27.

[Drugs Effect on Cognition in the Elderly].

Brefel-Courbon C.

Therapie. 2015 Nov-Dec;70(6):523-6. doi: 10.2515/therapie/2015038. Epub 2015 Jul 28. Review. French.

PMID:
26220919
28.

International validation of a behavioral scale in Parkinson's disease without dementia.

Rieu I, Martinez-Martin P, Pereira B, De Chazeron I, Verhagen Metman L, Jahanshahi M, Ardouin C, Chéreau I, Brefel-Courbon C, Ory-Magne F, Klinger H, Peyrol F, Schupbach M, Dujardin K, Tison F, Houeto JL, Krack P, Durif F.

Mov Disord. 2015 Apr 15;30(5):705-13. doi: 10.1002/mds.26223. Epub 2015 Mar 21.

PMID:
25809278
29.

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.

Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group.

Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23.

30.

An individual rehabilitation program: evaluation by Parkinsonian patients and their physiotherapists.

Ory Magne F, Fabre N, Gu C, Pastorelli C, Tardez S, Marchat JC, Marque P, Brefel Courbon C.

Rev Neurol (Paris). 2014 Nov;170(11):680-4. doi: 10.1016/j.neurol.2014.05.009. Epub 2014 Oct 3.

PMID:
25287732
31.

Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease.

Pellaprat J, Ory-Magne F, Canivet C, Simonetta-Moreau M, Lotterie JA, Radji F, Arbus C, Gerdelat A, Chaynes P, Brefel-Courbon C.

Parkinsonism Relat Disord. 2014 Jun;20(6):662-4. doi: 10.1016/j.parkreldis.2014.03.011. Epub 2014 Mar 20.

PMID:
24685343
32.

Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.

Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, Dellapina E, Destée A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, Sommet A, Viallet F, Vidailhet M, Rascol O; NS-Park CIC Network.

Neurology. 2014 Jan 28;82(4):300-7. doi: 10.1212/WNL.0000000000000050. Epub 2013 Dec 26.

PMID:
24371304
33.

[A therapeutic educational program in Parkinson's disease: ETPARK].

Ory Magne F, Arcari C, Canivet C, Sarrail M, Fabre MH, Mohara C, Brefel Courbon C.

Rev Neurol (Paris). 2014 Feb;170(2):128-33. doi: 10.1016/j.neurol.2013.08.007. Epub 2013 Nov 20. French.

PMID:
24267951
34.

Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease.

Gallini A, Gardette V, Vellas B, Lapeyre-Mestre M, Andrieu S, Brefel-Courbon C; REAL.FR/DSA group.

Drugs Aging. 2013 Jun;30(6):439-45. doi: 10.1007/s40266-013-0070-3.

35.

Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease.

Brefel-Courbon C, Ory-Magne F, Thalamas C, Payoux P, Rascol O.

Parkinsonism Relat Disord. 2013 May;19(5):548-52. doi: 10.1016/j.parkreldis.2013.02.003. Epub 2013 Feb 23.

PMID:
23462484
36.

Neurostimulation for Parkinson's disease with early motor complications.

Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group.

N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158.

37.

Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.

Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Brefel-Courbon C, Montastruc JL, Rascol O.

Clin Neuropharmacol. 2012 Nov-Dec;35(6):261-5. doi: 10.1097/WNF.0b013e31826e6e6d.

PMID:
23123689
38.

Effect of subthalamic deep brain stimulation on pain in Parkinson's disease.

Dellapina E, Ory-Magne F, Regragui W, Thalamas C, Lazorthes Y, Rascol O, Payoux P, Brefel-Courbon C.

Pain. 2012 Nov;153(11):2267-73. doi: 10.1016/j.pain.2012.07.026. Epub 2012 Sep 7.

PMID:
22964434
39.

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.

Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Sablonniere B, Azulay JP, Tison F, Rascol O, Vidailhet M, Destée A, Bloem BR, Bordet R, Devos D; Parkgait-II study group.

Lancet Neurol. 2012 Jul;11(7):589-96. doi: 10.1016/S1474-4422(12)70106-0. Epub 2012 Jun 1. Erratum in: Lancet Neurol. 2012 Aug;11(8):658. Lancet Neurol. 2016 Mar;15(3):241. Erratum in: Lancet Neurol. 2016 Mar;15(3):241.

PMID:
22658702
40.

Emerging analgesic drugs for Parkinson's disease.

Perez-Lloret S, Rey MV, Dellapina E, Pellaprat J, Brefel-Courbon C, Rascol O.

Expert Opin Emerg Drugs. 2012 Jun;17(2):157-71. doi: 10.1517/14728214.2012.677949. Epub 2012 Apr 25. Review.

PMID:
22530847
41.

Identification of VPS35 mutations replicated in French families with Parkinson disease.

Lesage S, Condroyer C, Klebe S, Honoré A, Tison F, Brefel-Courbon C, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group.

Neurology. 2012 May 1;78(18):1449-50. doi: 10.1212/WNL.0b013e318253d5f2. Epub 2012 Apr 18. No abstract available.

PMID:
22517097
42.

Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.

Dellapina E, Gerdelat-Mas A, Ory-Magne F, Pourcel L, Galitzky M, Calvas F, Simonetta-Moreau M, Thalamas C, Payoux P, Brefel-Courbon C.

Mov Disord. 2011 Jan;26(1):153-7. doi: 10.1002/mds.23406. Epub 2010 Oct 19.

PMID:
20960436
43.

Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.

Marchand-Pauvert V, Gerdelat-Mas A, Ory-Magne F, Calvas F, Mazevet D, Meunier S, Brefel-Courbon C, Vidailhet M, Simonetta-Moreau M.

Clin Neurophysiol. 2011 May;122(5):1019-26. doi: 10.1016/j.clinph.2010.08.015. Epub 2010 Oct 12.

PMID:
20943434
44.

Motor activation in multiple system atrophy and Parkinson disease: a PET study.

Payoux P, Brefel-Courbon C, Ory-Magne F, Regragui W, Thalamas C, Balduyck S, Durif F, Azulay JP, Tison F, Blin O, Esquerre JP, Rascol O.

Neurology. 2010 Sep 28;75(13):1174-80. doi: 10.1212/WNL.0b013e3181f4d78f.

PMID:
20876470
45.

Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.

Rascol O, Azulay JP, Blin O, Bonnet AM, Brefel-Courbon C, Césaro P, Damier P, Debilly B, Durif F, Galitzky M, Grouin JM, Pennaforte S, Villafane G, Yaici S, Agid Y.

Mov Disord. 2010 Feb 15;25(3):368-76. doi: 10.1002/mds.22922.

PMID:
20063435
46.

[Digestive disturbances in Parkinson disease].

Brefel-Courbon C.

Rev Neurol (Paris). 2009 Apr;165 Spec No 2:F63-5. Review. French. No abstract available.

PMID:
19593862
47.

Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC).

Ory-Magne F, Brefel-Courbon C, Payoux P, Debruxelles S, Sibon I, Goizet C, Labauge P, Menegon P, Uro-Coste E, Ghetti B, Delisle MB, Vidal R, Rascol O.

Mov Disord. 2009 Aug 15;24(11):1676-83. doi: 10.1002/mds.22669.

PMID:
19514068
48.

Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease.

Lesage S, Condroyer C, Lannuzel A, Lohmann E, Troiano A, Tison F, Damier P, Thobois S, Ouvrard-Hernandez AM, Rivaud-Péchoux S, Brefel-Courbon C, Destée A, Tranchant C, Romana M, Leclere L, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group.

J Med Genet. 2009 Jul;46(7):458-64. doi: 10.1136/jmg.2008.062612. Epub 2009 Apr 8.

PMID:
19357115
49.

Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.

Ibáñez P, Lesage S, Janin S, Lohmann E, Durif F, Destée A, Bonnet AM, Brefel-Courbon C, Heath S, Zelenika D, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group.

Arch Neurol. 2009 Jan;66(1):102-8. doi: 10.1001/archneurol.2008.555.

PMID:
19139307
50.

Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population.

Brefel-Courbon C, Grolleau S, Thalamas C, Bourrel R, Allaria-Lapierre V, Loï R, Micallef-Roll J, Lapeyre-Mestre M.

Pain. 2009 Jan;141(1-2):14-8. doi: 10.1016/j.pain.2008.04.026. Epub 2008 Dec 4.

PMID:
19062167

Supplemental Content

Loading ...
Support Center